These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minnesota
|
|
41-1597886
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
9800 59th Avenue North
|
|
|
|
Minneapolis, Minnesota
|
|
55442
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer
|
ý
|
|
|
Accelerated filer
o
|
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Item 1.
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
|
|
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
|
|
(unaudited)
March 29, 2014 |
|
December 28,
2013 |
||||
|
Assets
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
60,409
|
|
|
$
|
58,223
|
|
|
Marketable debt securities – current
|
52,147
|
|
|
52,159
|
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $418 and $425, respectively
|
15,579
|
|
|
14,979
|
|
||
|
Inventories
|
44,590
|
|
|
40,152
|
|
||
|
Prepaid expenses
|
7,923
|
|
|
9,216
|
|
||
|
Deferred income taxes
|
6,926
|
|
|
6,936
|
|
||
|
Other current assets
|
8,613
|
|
|
7,874
|
|
||
|
Total current assets
|
196,187
|
|
|
189,539
|
|
||
|
|
|
|
|
|
|||
|
Non-current assets:
|
|
|
|
|
|||
|
Marketable debt securities – non-current
|
30,469
|
|
|
34,632
|
|
||
|
Property and equipment, net
|
137,567
|
|
|
129,542
|
|
||
|
Goodwill and intangible assets, net
|
16,613
|
|
|
16,823
|
|
||
|
Deferred income taxes
|
6,396
|
|
|
4,943
|
|
||
|
Other assets
|
6,229
|
|
|
6,286
|
|
||
|
Total assets
|
$
|
393,461
|
|
|
$
|
381,765
|
|
|
|
|
|
|
|
|||
|
Liabilities and Shareholders’ Equity
|
|
|
|
|
|||
|
Current liabilities:
|
|
|
|
|
|||
|
Accounts payable
|
$
|
63,385
|
|
|
$
|
73,391
|
|
|
Customer prepayments
|
20,177
|
|
|
15,392
|
|
||
|
Accrued sales returns
|
10,737
|
|
|
9,433
|
|
||
|
Compensation and benefits
|
19,493
|
|
|
15,242
|
|
||
|
Taxes and withholding
|
16,514
|
|
|
12,517
|
|
||
|
Other current liabilities
|
10,410
|
|
|
11,207
|
|
||
|
Total current liabilities
|
140,716
|
|
|
137,182
|
|
||
|
|
|
|
|
|
|||
|
Non-current liabilities:
|
|
|
|
|
|||
|
Warranty liabilities
|
1,897
|
|
|
1,567
|
|
||
|
Other long-term liabilities
|
18,725
|
|
|
17,796
|
|
||
|
Total liabilities
|
161,338
|
|
|
156,545
|
|
||
|
|
|
|
|
|
|||
|
Shareholders’ equity:
|
|
|
|
|
|||
|
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value; 142,500 shares authorized, 54,273 and 54,901 shares issued and outstanding, respectively
|
543
|
|
|
549
|
|
||
|
Additional paid-in capital
|
—
|
|
|
5,382
|
|
||
|
Retained earnings
|
231,557
|
|
|
219,276
|
|
||
|
Accumulated other comprehensive income
|
23
|
|
|
13
|
|
||
|
Total shareholders’ equity
|
232,123
|
|
|
225,220
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
393,461
|
|
|
$
|
381,765
|
|
|
|
Three Months Ended
|
||||||
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Net sales
|
$
|
276,412
|
|
|
$
|
258,237
|
|
|
Cost of sales
|
105,029
|
|
|
94,821
|
|
||
|
Gross profit
|
171,383
|
|
|
163,416
|
|
||
|
|
|
|
|
|
|||
|
Operating expenses:
|
|
|
|
|
|||
|
Sales and marketing
|
125,022
|
|
|
109,813
|
|
||
|
General and administrative
|
18,896
|
|
|
15,820
|
|
||
|
Research and development
|
1,663
|
|
|
2,556
|
|
||
|
Total operating expenses
|
145,581
|
|
|
128,189
|
|
||
|
Operating income
|
25,802
|
|
|
35,227
|
|
||
|
Other income, net
|
102
|
|
|
91
|
|
||
|
Income before income taxes
|
25,904
|
|
|
35,318
|
|
||
|
Income tax expense
|
8,912
|
|
|
11,847
|
|
||
|
Net income
|
$
|
16,992
|
|
|
$
|
23,471
|
|
|
|
|
|
|
||||
|
Basic net income per share:
|
|
|
|
|
|
||
|
Net income per share – basic
|
$
|
0.31
|
|
|
$
|
0.43
|
|
|
Weighted-average shares – basic
|
54,113
|
|
|
55,095
|
|
||
|
Diluted net income per share:
|
|
|
|
|
|
||
|
Net income per share – diluted
|
$
|
0.31
|
|
|
$
|
0.42
|
|
|
Weighted-average shares – diluted
|
54,844
|
|
|
56,251
|
|
||
|
|
Three Months Ended
|
||||||
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Net income
|
$
|
16,992
|
|
|
$
|
23,471
|
|
|
Other comprehensive income (loss) – unrealized gain (loss) on available-for-sale marketable debt securities, net of income tax
|
10
|
|
|
(7
|
)
|
||
|
Comprehensive income
|
$
|
17,002
|
|
|
$
|
23,464
|
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income
|
|
Total
|
|||||||||||||
|
|
Shares
|
|
Amount
|
|
|
|
|
|||||||||||||||
|
Balance at December 28, 2013
|
54,901
|
|
|
$
|
549
|
|
|
$
|
5,382
|
|
|
$
|
219,276
|
|
|
$
|
13
|
|
|
$
|
225,220
|
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
16,992
|
|
|
—
|
|
|
16,992
|
|
|||||
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Unrealized gain on available-for-sale marketable debt securities, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10
|
|
|
10
|
|
|||||
|
Exercise of common stock options
|
32
|
|
|
—
|
|
|
411
|
|
|
—
|
|
|
—
|
|
|
411
|
|
|||||
|
Tax effect from stock-based compensation
|
—
|
|
|
—
|
|
|
(166
|
)
|
|
—
|
|
|
—
|
|
|
(166
|
)
|
|||||
|
Stock-based compensation
|
(80
|
)
|
|
—
|
|
|
(108
|
)
|
|
—
|
|
|
—
|
|
|
(108
|
)
|
|||||
|
Repurchases of common stock
|
(580
|
)
|
|
(6
|
)
|
|
(5,519
|
)
|
|
(4,711
|
)
|
|
—
|
|
|
(10,236
|
)
|
|||||
|
Balance at March 29, 2014
|
54,273
|
|
|
$
|
543
|
|
|
$
|
—
|
|
|
$
|
231,557
|
|
|
$
|
23
|
|
|
$
|
232,123
|
|
|
|
Three Months Ended
|
||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income
|
$
|
16,992
|
|
|
$
|
23,471
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|||
|
Depreciation and amortization
|
9,176
|
|
|
6,661
|
|
||
|
Stock-based compensation
|
(108
|
)
|
|
432
|
|
||
|
Net (gain) loss on disposals and impairments of assets
|
(2
|
)
|
|
27
|
|
||
|
Excess tax benefits from stock-based compensation
|
(19
|
)
|
|
(2,401
|
)
|
||
|
Deferred income taxes
|
(1,450
|
)
|
|
585
|
|
||
|
Changes in operating assets and liabilities, net of effect of acquisition:
|
|
|
|
|
|||
|
Accounts receivable
|
(552
|
)
|
|
2,454
|
|
||
|
Inventories
|
(4,438
|
)
|
|
5,269
|
|
||
|
Income taxes
|
3,795
|
|
|
7,534
|
|
||
|
Prepaid expenses and other assets
|
1,030
|
|
|
(889
|
)
|
||
|
Accounts payable
|
3,600
|
|
|
12,955
|
|
||
|
Customer prepayments
|
4,785
|
|
|
2,302
|
|
||
|
Accrued compensation and benefits
|
4,080
|
|
|
(9,165
|
)
|
||
|
Other taxes and withholding
|
36
|
|
|
(1,443
|
)
|
||
|
Warranty liabilities
|
185
|
|
|
(239
|
)
|
||
|
Other accruals and liabilities
|
1,754
|
|
|
(2,531
|
)
|
||
|
Net cash provided by operating activities
|
38,864
|
|
|
45,022
|
|
||
|
|
|
|
|
||||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Purchases of property and equipment
|
(16,660
|
)
|
|
(14,309
|
)
|
||
|
Proceeds from maturities of marketable debt securities
|
10,000
|
|
|
5,898
|
|
||
|
Investments in marketable debt securities
|
(13,623
|
)
|
|
(12,883
|
)
|
||
|
Increase in restricted cash
|
(500
|
)
|
|
—
|
|
||
|
Proceeds from sales of property and equipment
|
5
|
|
|
3
|
|
||
|
Acquisition of business
|
—
|
|
|
(15,500
|
)
|
||
|
Investment in non-marketable equity securities
|
—
|
|
|
(1,500
|
)
|
||
|
Net cash used in investing activities
|
(20,778
|
)
|
|
(38,291
|
)
|
||
|
|
|
|
|
||||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Repurchases of common stock
|
(10,236
|
)
|
|
(10,144
|
)
|
||
|
Net decrease in short-term borrowings
|
(6,094
|
)
|
|
(4,370
|
)
|
||
|
Proceeds from issuance of common stock
|
411
|
|
|
2,282
|
|
||
|
Excess tax benefits from stock-based compensation
|
19
|
|
|
2,401
|
|
||
|
Net cash used in financing activities
|
(15,900
|
)
|
|
(9,831
|
)
|
||
|
|
|
|
|
||||
|
Net increase (decrease) in cash and cash equivalents
|
2,186
|
|
|
(3,100
|
)
|
||
|
Cash and cash equivalents, at beginning of period
|
58,223
|
|
|
87,915
|
|
||
|
Cash and cash equivalents, at end of period
|
$
|
60,409
|
|
|
$
|
84,815
|
|
|
|
|
March 29, 2014
|
||||||||||||||
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
Marketable debt securities – current
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities
|
|
$
|
15,009
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
15,009
|
|
|
Corporate bonds
|
|
—
|
|
|
20,356
|
|
|
—
|
|
|
20,356
|
|
||||
|
U.S. Agency bonds
|
|
—
|
|
|
12,018
|
|
|
—
|
|
|
12,018
|
|
||||
|
Municipal bonds
|
|
—
|
|
|
4,764
|
|
|
—
|
|
|
4,764
|
|
||||
|
|
|
15,009
|
|
|
37,138
|
|
|
—
|
|
|
52,147
|
|
||||
|
Marketable debt securities – non-current
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities
|
|
8,989
|
|
|
—
|
|
|
—
|
|
|
8,989
|
|
||||
|
Corporate bonds
|
|
—
|
|
|
10,303
|
|
|
—
|
|
|
10,303
|
|
||||
|
U.S. Agency bonds
|
|
—
|
|
|
7,502
|
|
|
—
|
|
|
7,502
|
|
||||
|
Municipal bonds
|
|
—
|
|
|
3,675
|
|
|
—
|
|
|
3,675
|
|
||||
|
|
|
8,989
|
|
|
21,480
|
|
|
—
|
|
|
30,469
|
|
||||
|
|
|
$
|
23,998
|
|
|
$
|
58,618
|
|
|
$
|
—
|
|
|
$
|
82,616
|
|
|
|
|
December 28, 2013
|
||||||||||||||
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
|
Marketable debt securities – current
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities
|
|
$
|
15,011
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
15,011
|
|
|
Corporate bonds
|
|
—
|
|
|
20,300
|
|
|
—
|
|
|
20,300
|
|
||||
|
U.S. Agency bonds
|
|
—
|
|
|
12,025
|
|
|
—
|
|
|
12,025
|
|
||||
|
Municipal bonds
|
|
—
|
|
|
4,823
|
|
|
—
|
|
|
4,823
|
|
||||
|
|
|
15,011
|
|
|
37,148
|
|
|
—
|
|
|
52,159
|
|
||||
|
Marketable debt securities – non-current
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury securities
|
|
8,978
|
|
|
—
|
|
|
—
|
|
|
8,978
|
|
||||
|
Corporate bonds
|
|
—
|
|
|
15,484
|
|
|
—
|
|
|
15,484
|
|
||||
|
U.S. Agency bonds
|
|
—
|
|
|
7,498
|
|
|
—
|
|
|
7,498
|
|
||||
|
Municipal bonds
|
|
—
|
|
|
2,672
|
|
|
—
|
|
|
2,672
|
|
||||
|
|
|
8,978
|
|
|
25,654
|
|
|
—
|
|
|
34,632
|
|
||||
|
|
|
$
|
23,989
|
|
|
$
|
62,802
|
|
|
$
|
—
|
|
|
$
|
86,791
|
|
|
|
March 29, 2014
|
||||||||||||||
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value
|
||||||||
|
U.S. Treasury securities
|
$
|
23,979
|
|
|
$
|
19
|
|
|
$
|
—
|
|
|
$
|
23,998
|
|
|
Corporate bonds
|
30,669
|
|
|
5
|
|
|
(15
|
)
|
|
30,659
|
|
||||
|
U.S. Agency bonds
|
19,516
|
|
|
10
|
|
|
(6
|
)
|
|
19,520
|
|
||||
|
Municipal bonds
|
8,414
|
|
|
25
|
|
|
—
|
|
|
8,439
|
|
||||
|
|
$
|
82,578
|
|
|
$
|
59
|
|
|
$
|
(21
|
)
|
|
$
|
82,616
|
|
|
|
December 28, 2013
|
||||||||||||||
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair
Value
|
||||||||
|
U.S. Treasury securities
|
$
|
23,975
|
|
|
$
|
15
|
|
|
$
|
(1
|
)
|
|
$
|
23,989
|
|
|
Corporate bonds
|
35,804
|
|
|
3
|
|
|
(23
|
)
|
|
35,784
|
|
||||
|
U.S. Agency bonds
|
19,517
|
|
|
10
|
|
|
(4
|
)
|
|
19,523
|
|
||||
|
Municipal bonds
|
7,474
|
|
|
23
|
|
|
(2
|
)
|
|
7,495
|
|
||||
|
|
$
|
86,770
|
|
|
$
|
51
|
|
|
$
|
(30
|
)
|
|
$
|
86,791
|
|
|
|
March 29, 2014
|
|
December 28, 2013
|
||||||||||||
|
|
Amortized
Cost
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Fair
Value
|
||||||||
|
Marketable debt securities – current (due in less than one year)
|
$
|
52,112
|
|
|
$
|
52,147
|
|
|
$
|
52,122
|
|
|
$
|
52,159
|
|
|
Marketable debt securities – non-current (due in one to two years)
|
30,466
|
|
|
30,469
|
|
|
34,648
|
|
|
34,632
|
|
||||
|
|
$
|
82,578
|
|
|
$
|
82,616
|
|
|
$
|
86,770
|
|
|
$
|
86,791
|
|
|
|
March 29,
2014 |
|
December 28,
2013 |
||||
|
Raw materials
|
$
|
8,234
|
|
|
$
|
7,118
|
|
|
Work in progress
|
507
|
|
|
505
|
|
||
|
Finished goods
|
35,849
|
|
|
32,529
|
|
||
|
|
$
|
44,590
|
|
|
$
|
40,152
|
|
|
|
Three Months Ended
|
|
Three Months Ended
|
||||||||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
||||||||||||
|
|
Goodwill
|
|
Indefinite-Lived
Trade Name/ Trademarks |
|
Goodwill
|
|
Indefinite-Lived
Trade Name/ Trademarks |
||||||||
|
Beginning balance
|
$
|
8,963
|
|
|
$
|
1,396
|
|
|
$
|
2,850
|
|
|
$
|
—
|
|
|
Comfortaire purchase
|
—
|
|
|
—
|
|
|
6,157
|
|
|
1,396
|
|
||||
|
Ending balance
|
$
|
8,963
|
|
|
$
|
1,396
|
|
|
$
|
9,007
|
|
|
$
|
1,396
|
|
|
|
March 29, 2014
|
|
December 28, 2013
|
||||||||||||
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
||||||||
|
Developed technologies
|
$
|
5,231
|
|
|
$
|
974
|
|
|
$
|
5,231
|
|
|
$
|
850
|
|
|
Customer relationships
|
2,413
|
|
|
416
|
|
|
2,413
|
|
|
330
|
|
||||
|
Trade names/trademarks
|
101
|
|
|
101
|
|
|
101
|
|
|
101
|
|
||||
|
|
$
|
7,745
|
|
|
$
|
1,491
|
|
|
$
|
7,745
|
|
|
$
|
1,281
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 29, 2014
|
|
March 30, 2013
|
||||
|
Amount repurchased under Board-approved share repurchase program
|
|
$
|
10,011
|
|
|
$
|
10,009
|
|
|
Amount repurchased in connection with the vesting of employee restricted stock grants
|
|
225
|
|
|
135
|
|
||
|
Total amount repurchased
|
|
$
|
10,236
|
|
|
$
|
10,144
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 29, 2014
|
|
March 30, 2013
|
||||
|
Options
|
|
$
|
235
|
|
|
$
|
545
|
|
|
Restricted shares
|
|
(343
|
)
|
|
(113
|
)
|
||
|
Total stock-based compensation (benefit) expense
(1)
|
|
(108
|
)
|
|
432
|
|
||
|
Income tax expense (benefit)
|
|
37
|
|
|
(148
|
)
|
||
|
Total stock-based compensation (benefit) expense, net of tax
|
|
$
|
(71
|
)
|
|
$
|
284
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Interest income
|
$
|
112
|
|
|
$
|
105
|
|
|
Interest expense
|
(10
|
)
|
|
(14
|
)
|
||
|
Other income, net
|
$
|
102
|
|
|
$
|
91
|
|
|
|
Three Months Ended
|
||||||
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Net income
|
$
|
16,992
|
|
|
$
|
23,471
|
|
|
|
|
|
|
||||
|
Reconciliation of weighted-average shares outstanding:
|
|
|
|
|
|
||
|
Basic weighted-average shares outstanding
|
54,113
|
|
|
55,095
|
|
||
|
Effect of dilutive securities:
|
|
|
|
||||
|
Options
|
353
|
|
|
690
|
|
||
|
Restricted shares
|
378
|
|
|
466
|
|
||
|
Diluted weighted-average shares outstanding
|
54,844
|
|
|
56,251
|
|
||
|
|
|
|
|
||||
|
Net income per share – basic
|
$
|
0.31
|
|
|
$
|
0.43
|
|
|
Net income per share – diluted
|
$
|
0.31
|
|
|
$
|
0.42
|
|
|
|
Three Months Ended
|
||||||
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Balance at beginning of year
|
$
|
9,433
|
|
|
$
|
5,330
|
|
|
Additions that reduce net sales
|
19,021
|
|
|
12,963
|
|
||
|
Deductions from reserves
|
(17,717
|
)
|
|
(13,230
|
)
|
||
|
Acquired sales return reserve
(1)
|
—
|
|
|
50
|
|
||
|
Balance at end of period
|
$
|
10,737
|
|
|
$
|
5,113
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Balance at beginning of year
|
$
|
4,153
|
|
|
$
|
4,858
|
|
|
Additions charged to costs and expenses for current-year sales
|
1,568
|
|
|
1,469
|
|
||
|
Deductions from reserves
|
(1,536
|
)
|
|
(1,403
|
)
|
||
|
Changes in liability for pre-existing warranties during the current year, including expirations
|
153
|
|
|
(306
|
)
|
||
|
Acquired warranty reserve
(1)
|
—
|
|
|
658
|
|
||
|
Balance at end of period
|
$
|
4,338
|
|
|
$
|
5,276
|
|
|
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
•
|
Risk Factors
|
|
•
|
Overview
|
|
•
|
Results of Operations
|
|
•
|
Liquidity and Capital Resources
|
|
•
|
Non-GAAP Data Reconciliations
|
|
•
|
Off-Balance-Sheet Arrangements and Contractual Obligations
|
|
•
|
Critical Accounting Policies
|
|
•
|
Current and future general and industry economic trends and consumer confidence;
|
|
•
|
The effectiveness of our marketing messages;
|
|
•
|
The efficiency of our advertising and promotional efforts;
|
|
•
|
Our ability to execute our Company-Controlled distribution strategy;
|
|
•
|
Our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates;
|
|
•
|
Our ability to continue to improve and expand our product line, and consumer acceptance of our products, product quality, innovation and brand image;
|
|
•
|
Industry competition, the emergence of additional competitive products, and the adequacy of our intellectual property rights to protect our products and brand from competitive or infringing activities;
|
|
•
|
Availability of attractive and cost-effective consumer credit options;
|
|
•
|
Pending and unforeseen litigation and the potential for adverse publicity associated with litigation;
|
|
•
|
Our “just-in-time” manufacturing processes with minimal levels of inventory, which may leave us vulnerable to shortages in supply;
|
|
•
|
Our dependence on significant suppliers and our ability to maintain relationships with key suppliers, including several sole-source suppliers;
|
|
•
|
Rising commodity costs and other inflationary pressures;
|
|
•
|
Risks inherent in global sourcing activities;
|
|
•
|
Risks of disruption in the operation of either of our two primary manufacturing facilities;
|
|
•
|
Increasing government regulation;
|
|
•
|
The adequacy of our management information systems to meet the evolving needs of our business and existing and evolving regulatory standards applicable to data privacy and security;
|
|
•
|
The costs and potential disruptions to our business related to upgrading our management information systems, including the digital platform supporting our website;
|
|
•
|
Our ability to attract, retain and motivate qualified management, executive and other key employees, including qualified retail sales professionals and managers; and
|
|
•
|
Uncertainties arising from global events, such as terrorist attacks or a pandemic outbreak, or the threat of such events.
|
|
•
|
Everyone will know Sleep Number®;
|
|
•
|
Innovative Sleep Number® products will deliver meaningful benefits;
|
|
•
|
Customers will easily find and interact with Sleep Number;
|
|
•
|
Customers will enthusiastically recommend Sleep Number; and
|
|
•
|
We will leverage our business model to fund innovation and growth.
|
|
•
|
Net sales
increased
7%
to
$276.4 million
, compared with
$258.2 million
for the same period one year ago. Company-Controlled comparable sales increased 2%. The net sales increase was primarily driven by sales from
32
net new stores opened in the past 12 months.
|
|
•
|
Retail sales-per-store (for stores open at least one year), on a trailing twelve-month basis, of
$2.1 million
were in line with sales-per-store in the comparable period one year ago.
|
|
•
|
Operating income decreased to
$25.8 million
, or
9.3%
of net sales, compared with
$35.2 million
, or
13.6%
of net sales, for the same period one year ago. The decline in operating income was primarily driven by a 1.3 percentage point (ppt.) decrease in our gross profit rate and a 2.7 ppt. increase in our sales and marketing expense rate. See page 18 for additional details.
|
|
•
|
Net income
decreased
28%
to
$17.0 million
, or
$0.31
per diluted share, compared with net income of
$23.5 million
, or
$0.42
per diluted share, for the same period one year ago.
|
|
•
|
Cash provided by operating activities totaled
$38.9 million
for the
three months ended
March 29, 2014
, compared with
$45.0 million
for the same period one year ago.
|
|
•
|
At
March 29, 2014
, cash, cash equivalents and marketable debt securities totaled
$143.0 million
and we had no borrowings under our revolving credit facility. In the
first
quarter of
2014
, we repurchased
566,543
shares of our common stock under our Board-approved share repurchase program at a cost of
$10.0 million
(
$17.67
per share). As of March 29, 2014, the remaining authorization under our Board-approved share repurchase program was $126.7 million.
|
|
|
|
Three Months Ended
|
||||||||||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
||||||||||
|
Net sales
|
|
$
|
276.4
|
|
|
100.0
|
%
|
|
$
|
258.2
|
|
|
100.0
|
%
|
|
Cost of sales
|
|
105.0
|
|
|
38.0
|
%
|
|
94.8
|
|
|
36.7
|
%
|
||
|
Gross profit
|
|
171.4
|
|
|
62.0
|
%
|
|
163.4
|
|
|
63.3
|
%
|
||
|
|
|
|
|
|
|
|
|
|
||||||
|
Operating expenses:
|
|
|
|
|
|
|
|
|
||||||
|
Sales and marketing
|
|
125.0
|
|
|
45.2
|
%
|
|
109.8
|
|
|
42.5
|
%
|
||
|
General and administrative
|
|
18.9
|
|
|
6.8
|
%
|
|
15.8
|
|
|
6.1
|
%
|
||
|
Research and development
|
|
1.7
|
|
|
0.6
|
%
|
|
2.6
|
|
|
1.0
|
%
|
||
|
Total operating expenses
|
|
145.6
|
|
|
52.7
|
%
|
|
128.2
|
|
|
49.6
|
%
|
||
|
Operating income
|
|
25.8
|
|
|
9.3
|
%
|
|
35.2
|
|
|
13.6
|
%
|
||
|
Operating income – as adjusted
(1)
|
|
25.8
|
|
|
9.3
|
%
|
|
34.8
|
|
|
13.5
|
%
|
||
|
Other income, net
|
|
0.1
|
|
|
0.0
|
%
|
|
0.1
|
|
|
0.0
|
%
|
||
|
Income before income taxes
|
|
25.9
|
|
|
9.4
|
%
|
|
35.3
|
|
|
13.7
|
%
|
||
|
Income tax expense
|
|
8.9
|
|
|
3.2
|
%
|
|
11.8
|
|
|
4.6
|
%
|
||
|
Net income
|
|
$
|
17.0
|
|
|
6.1
|
%
|
|
$
|
23.5
|
|
|
9.1
|
%
|
|
Net income – as adjusted
(1)
|
|
$
|
17.0
|
|
|
6.1
|
%
|
|
$
|
23.2
|
|
|
9.0
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Basic
|
|
$
|
0.31
|
|
|
|
|
|
$
|
0.43
|
|
|
|
|
|
Diluted
|
|
$
|
0.31
|
|
|
|
|
|
$
|
0.42
|
|
|
|
|
|
Diluted – as adjusted
(1)
|
|
$
|
0.31
|
|
|
|
|
$
|
0.41
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||||||
|
Weighted-average number of common shares:
|
|
|
|
|
|
|
|
|||||||
|
Basic
|
|
54.1
|
|
|
|
|
|
55.1
|
|
|
|
|||
|
Diluted
|
|
54.8
|
|
|
|
|
|
56.3
|
|
|
|
|||
|
|
|
(1)
|
This non-GAAP measure is not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates annual and year-over-year comparisons for investors and financial analysts. See page 20 for a reconciliation of this non-GAAP measure to the appropriate GAAP measure.
|
|
|
|
Three Months Ended
|
||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
||
|
Company-Controlled channel
|
|
96.1
|
%
|
|
94.8
|
%
|
|
Wholesale/Other channel
|
|
3.9
|
%
|
|
5.2
|
%
|
|
Total
|
|
100.0
|
%
|
|
100.0
|
%
|
|
|
|
Three Months Ended
|
||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
||
|
Sales change rates:
|
|
|
|
|
||
|
Retail comparable-store sales
(1)
|
|
2
|
%
|
|
(8
|
%)
|
|
Direct and E-Commerce
|
|
2
|
%
|
|
(18
|
%)
|
|
Company-Controlled comparable sales change
|
|
2
|
%
|
|
(9
|
%)
|
|
Net store openings/closings
|
|
7
|
%
|
|
6
|
%
|
|
Total Company-Controlled channel
|
|
9
|
%
|
|
(3
|
%)
|
|
Wholesale/Other channel
|
|
(21
|
%)
|
|
35
|
%
|
|
Total net sales change
|
|
7
|
%
|
|
(2
|
%)
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Average sales per store
(1)
($ in thousands)
|
|
$
|
2,120
|
|
|
$
|
2,118
|
|
|
Average sales per square foot
(1)
|
|
$
|
1,042
|
|
|
$
|
1,256
|
|
|
Stores > $1 million in net sales
(1)
|
|
97
|
%
|
|
98
|
%
|
||
|
Stores > $2 million in net sales
(1)
|
|
47
|
%
|
|
46
|
%
|
||
|
Average net sales per mattress unit – Company-Controlled channel
(2)
|
|
$
|
3,373
|
|
|
$
|
3,132
|
|
|
|
|
|
|
Three Months Ended
|
||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
||
|
Beginning of period
|
|
440
|
|
|
410
|
|
|
Opened
|
|
17
|
|
|
10
|
|
|
Closed
|
|
(14
|
)
|
|
(9
|
)
|
|
End of period
|
|
443
|
|
|
411
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
||||
|
Total cash provided by (used in):
|
|
|
|
|
||||
|
Operating activities
|
|
$
|
38.9
|
|
|
$
|
45.0
|
|
|
Investing activities
|
|
(20.8
|
)
|
|
(38.3
|
)
|
||
|
Financing activities
|
|
(15.9
|
)
|
|
(9.8
|
)
|
||
|
Net increase (decrease) in cash and cash equivalents
|
|
$
|
2.2
|
|
|
$
|
(3.1
|
)
|
|
|
Three Months Ended
|
||||||||||||||
|
|
March 29, 2014
|
|
March 30, 2013
|
||||||||||||
|
|
As Reported
|
|
As Reported
|
|
CEO
Transition Benefit (1) |
|
As Adjusted
|
||||||||
|
Operating income
|
$
|
25,802
|
|
|
$
|
35,227
|
|
|
$
|
(391
|
)
|
|
$
|
34,836
|
|
|
Other income, net
|
102
|
|
|
91
|
|
|
—
|
|
|
91
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Income before income taxes
|
25,904
|
|
|
35,318
|
|
|
(391
|
)
|
|
34,927
|
|
||||
|
Income tax expense
(2)
|
8,912
|
|
|
11,847
|
|
|
(134
|
)
|
|
11,713
|
|
||||
|
Net income
|
$
|
16,992
|
|
|
$
|
23,471
|
|
|
$
|
(257
|
)
|
|
$
|
23,214
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per share –
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.31
|
|
|
$
|
0.43
|
|
|
$
|
0.00
|
|
|
$
|
0.42
|
|
|
Diluted
|
$
|
0.31
|
|
|
$
|
0.42
|
|
|
$
|
0.00
|
|
|
$
|
0.41
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic Shares
|
54,113
|
|
|
55,095
|
|
|
55,095
|
|
|
55,095
|
|
||||
|
Diluted Shares
|
54,844
|
|
|
56,251
|
|
|
56,251
|
|
|
56,251
|
|
||||
|
|
|
|
|
Three Months Ended
|
|
Trailing-Twelve
Months Ended
|
||||||||||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
|
March 29,
2014 |
|
March 30,
2013 |
||||||||
|
Net income
|
|
$
|
16,992
|
|
|
$
|
23,471
|
|
|
$
|
53,602
|
|
|
$
|
79,148
|
|
|
Income tax expense
|
|
8,912
|
|
|
11,847
|
|
|
27,995
|
|
|
41,872
|
|
||||
|
Interest expense
|
|
10
|
|
|
14
|
|
|
47
|
|
|
62
|
|
||||
|
Depreciation and amortization
|
|
8,885
|
|
|
6,333
|
|
|
32,151
|
|
|
21,838
|
|
||||
|
Stock-based compensation
|
|
(108
|
)
|
|
432
|
|
|
3,692
|
|
|
3,774
|
|
||||
|
Asset impairments
|
|
3
|
|
|
30
|
|
|
100
|
|
|
174
|
|
||||
|
Adjusted EBITDA
|
|
$
|
34,694
|
|
|
$
|
42,127
|
|
|
$
|
117,587
|
|
|
$
|
146,868
|
|
|
|
|
Three Months Ended
|
|
Trailing-Twelve
Months Ended
|
||||||||||||
|
|
|
March 29,
2014 |
|
March 30,
2013 |
|
March 29,
2014 |
|
March 30,
2013 |
||||||||
|
Net cash provided by operating activities
|
|
$
|
38,864
|
|
|
$
|
45,022
|
|
|
$
|
81,947
|
|
|
$
|
101,130
|
|
|
Subtract: Purchases of property and equipment
|
|
16,660
|
|
|
14,309
|
|
|
79,162
|
|
|
56,621
|
|
||||
|
Free cash flow
|
|
$
|
22,204
|
|
|
$
|
30,713
|
|
|
$
|
2,785
|
|
|
$
|
44,509
|
|
|
(a) – (b)
|
Not applicable.
|
|
(c)
|
Issuer Purchases of Equity Securities
|
|
Fiscal Period
|
|
Total
Number of Shares
Purchased
(1)(2)
|
|
Average
Price Paid
per Share
|
|
Total Number
of Shares
Purchased as
|
|
Approximate
Dollar Value
of Shares that
May Yet Be
Purchased
Under the
Plans or
Programs
|
||||||
|
December 29, 2013 through January 25, 2014
|
|
162,525
|
|
|
$
|
17.88
|
|
|
162,525
|
|
|
$
|
133,796,000
|
|
|
January 26, 2014 through February 22, 2014
|
|
115,401
|
|
|
17.32
|
|
|
115,401
|
|
|
131,797,000
|
|
||
|
February 23, 2014 through March 29, 2014
|
|
301,797
|
|
|
17.66
|
|
|
288,617
|
|
|
126,691,000
|
|
||
|
Total
|
|
579,723
|
|
|
$
|
17.66
|
|
|
566,543
|
|
|
$
|
126,691,000
|
|
|
|
|
(1)
|
Under the current Board-approved $290.0 million share repurchase program, we repurchased
566,543
shares of our common stock at a cost of
$10.0 million
(based on trade dates) during the three months ended
March 29, 2014
. As of
March 29, 2014
, the remaining authorization under our Board-approved share repurchase program was
$126.7 million
. There is no expiration date governing the period over which we can repurchase shares. Any repurchased shares are constructively retired and returned to an unissued status.
|
|
(2)
|
In connection with the vesting of employee restricted stock grants, we also repurchased
13,180
shares of our common stock at a cost of
$225 thousand
, during the three months ended
March 29, 2014
.
|
|
Exhibit
Number
|
|
Description
|
|
Method of Filing
|
|
|
|
|
|
|
|
10.1
|
|
Twelfth Amendment to Amended and Restated Private Label Consumer Credit Card Program Agreement dated and executed January 13, 2014
|
|
Incorporated by reference to Exhibit 10.1 contained in Select Comfort's Current Report on Form 8-K filed January 17, 2014
|
|
|
|
|
|
|
|
10.2
|
|
Thirteenth Amendment to Amended and Restated Private Label Consumer Credit Card Program Agreement dated and executed January 13, 2014
|
|
Incorporated by reference to Exhibit 10.2 contained in Select Comfort's Current Report on Form 8-K filed January 17, 2014
|
|
|
|
|
|
|
|
10.3
|
|
Offer Letter dated March 14, 2014 from Select Comfort Corporation to David R. Callen
|
|
Incorporated by reference to Exhibit 10.1 contained in Select Comfort's Current Report on Form 8-K filed March 20, 2014
|
|
|
|
|
|
|
|
31.1
|
|
Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith
|
|
|
|
|
|
|
|
31.2
|
|
Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith
|
|
|
|
|
|
|
|
32.1
|
|
Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
|
|
Furnished herewith
|
|
|
|
|
|
|
|
32.2
|
|
Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
|
|
Furnished herewith
|
|
|
|
|
|
|
|
101
|
|
The following financial information from the Company's Quarterly Report on Form 10-Q for the period ended March 29, 2014, filed with the SEC on April 25, 2014, formatted in eXtensible Business Reporting Language: (i) Condensed Consolidated Balance Sheets as of March 29, 2014 and December 28, 2013; (ii) Condensed Consolidated Statements of Operations for the three months ended March 29, 2014 and March 30, 2013; (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 29, 2014 and March 30, 2013; (iv) Condensed Consolidated Statement of Shareholders' Equity for the three months ended March 29, 2014; (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 29, 2014 and March 30, 2013; and (vi) Notes to Condensed Consolidated Financial Statements.
|
|
Filed herewith
|
|
|
|
SELECT COMFORT CORPORATION
|
|
||
|
|
|
(Registrant)
|
|
||
|
|
|
|
|
||
|
Dated:
|
April 25, 2014
|
By:
|
|
/s/ Shelly R. Ibach
|
|
|
|
|
|
|
Shelly R. Ibach
|
|
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
(principal executive officer)
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Robert J. Poirier
|
|
|
|
|
|
|
Robert J. Poirier
|
|
|
|
|
|
|
Chief Accounting Officer
|
|
|
|
|
|
|
(principal accounting officer)
|
|
|
Exhibit
Number
|
|
Description
|
|
Method of Filing
|
|
|
|
|
|
|
|
10.1
|
|
Twelfth Amendment to Amended and Restated Private Label Consumer Credit Card Program Agreement dated and executed January 13, 2014
|
|
Incorporated by reference to Exhibit 10.1 contained in Select Comfort's Current Report on Form 8-K filed January 17, 2014
|
|
|
|
|
|
|
|
10.2
|
|
Thirteenth Amendment to Amended and Restated Private Label Consumer Credit Card Program Agreement dated and executed January 13, 2014
|
|
Incorporated by reference to Exhibit 10.2 contained in Select Comfort's Current Report on Form 8-K filed January 17, 2014
|
|
|
|
|
|
|
|
10.3
|
|
Offer Letter dated March 14, 2014 from Select Comfort Corporation to David R. Callen
|
|
Incorporated by reference to Exhibit 10.1 contained in Select Comfort's Current Report on Form 8-K filed March 20, 2014
|
|
|
|
|
|
|
|
31.1
|
|
Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith
|
|
|
|
|
|
|
|
31.2
|
|
Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith
|
|
|
|
|
|
|
|
32.1
|
|
Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
|
|
Furnished herewith
|
|
|
|
|
|
|
|
32.2
|
|
Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
|
|
Furnished herewith
|
|
|
|
|
|
|
|
101
|
|
The following financial information from the Company's Quarterly Report on Form 10-Q for the period ended March 29, 2014, filed with the SEC on April 25, 2014, formatted in eXtensible Business Reporting Language: (i) Condensed Consolidated Balance Sheets as of March 29, 2014 and December 28, 2013; (ii) Condensed Consolidated Statements of Operations for the three months ended March 29, 2014 and March 30, 2013; (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 29, 2014 and March 30, 2013; (iv) Condensed Consolidated Statement of Shareholders' Equity for the three months ended March 29, 2014; (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 29, 2014 and March 30, 2013; and (vi) Notes to Condensed Consolidated Financial Statements.
|
|
Filed herewith
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|